Bio-Techne has grown revenue 2.5% a year over three years and 7.4% a year over five, with earnings per share compounding at −26%. Revenue growth, 3-year annual rate: +2.5% (Biotechnology median +21%). Revenue growth, 5-year rate: +7.4%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −26%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 17, FY2009 to FY2025, as filed.

TECHBio-Techne

HealthcareUSD

$72.39

$43.2252 weeks$72.51

Is it growing?

Is TECH growing?

Bio-Techne has grown revenue 2.5% a year over three years and 7.4% a year over five, with earnings per share compounding at −26%.

+2.5%

Revenue growth, 3-year annual rate · Biotechnology median +21% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +7.4%
Revenue growth, 5-year rate · +2.5% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −26%
Earnings per share, 3-year rate · revenue +2.5% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed